纳指生物科技ETF(513290)
动态评分: 5.70分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2024-12-31 | TKNO | Alpha Teknova Inc | 67.84 | 0.04% |
2024-12-31 | PRME | Prime Medicine Inc | 58.38 | 0.04% |
2024-12-31 | ZVRA | Zevra Therapeutics Inc | 67.85 | 0.04% |
2024-12-31 | ESPR | Esperion Therapeutics Inc | 66.07 | 0.04% |
2024-12-31 | ANAB | AnaptysBio Inc | 61.41 | 0.04% |
2024-12-31 | CDXS | Codexis Inc | 59.17 | 0.04% |
2024-12-31 | SANA | Sana Biotechnology Inc | 55.47 | 0.04% |
2024-12-31 | SIGA | 西佳科技 | 65.41 | 0.04% |
2024-12-31 | RGNX | REGENXBIO Inc | 58.37 | 0.04% |
2024-12-31 | ALLO | Allogene Therapeutics Inc | 68.07 | 0.04% |
2024-12-31 | MXCT | MaxCyte Inc | 66.88 | 0.04% |
2024-12-31 | PAHC | 美国辉宝 | 65.09 | 0.04% |
2024-12-31 | TSHA | Taysha Gene Therapies Inc | 54.04 | 0.04% |
2024-12-31 | ALMS | Alumis Inc | 56.57 | 0.04% |
2024-12-31 | OABI | OmniAb Inc | 65.29 | 0.04% |
2024-12-31 | AURA | Aura Biosciences Inc | 62.59 | 0.04% |
2024-12-31 | PSNL | Personalis Inc | 62.24 | 0.04% |
2024-12-31 | YMAB | Y-mAbs Therapeutics Inc | 53.45 | 0.04% |
2024-12-31 | GLPG | Galapagos NV ADR | 58.55 | 0.04% |
2024-12-31 | URGN | 乌龙制药 | 68.5 | 0.04% |
公告&资料
